You are here

Article info

Article menu
Coronary artery disease
Original research
Vall d’Hebron Risk Score II for myocardial infarction and cardiac death

Authors

  • Guillermo Romero-Farina Nuclear Cardiology, Department, Hospital Universitari Vall d'Hebron, Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, SpainCentro de Investigación Biomédica en Red: Enfermedades Cardiovasculares (CIBER-CV), Hospital Universitari Vall d'Hebron, Madrid, SpainGrup d'Imatge Mèdica Molecular (GRIMM), Vall d’Hebron University Hospital, Barcelona, SpainCardiology Department, Consorci Sanitari de l’Alt Penedès i Garraf (CSAPG), Barcelona, SpainCardiology Department, Hospital Universitari Vall d'Hebron, Valld’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Santiago Aguadé-Bruix Nuclear Cardiology, Department, Hospital Universitari Vall d'Hebron, Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, SpainCentro de Investigación Biomédica en Red: Enfermedades Cardiovasculares (CIBER-CV), Hospital Universitari Vall d'Hebron, Madrid, SpainGrup d'Imatge Mèdica Molecular (GRIMM), Vall d’Hebron University Hospital, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ignacio Ferreira González Cardiology Department, Hospital Universitari Vall d'Hebron, Valld’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, SpainCentro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBER-EP), Madrid, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Guillermo Romero-Farina; guiromfar{at}gmail.com
View Full Text

Citation

Romero-Farina G, Aguadé-Bruix S, Ferreira González I
Vall d’Hebron Risk Score II for myocardial infarction and cardiac death
Open Heart 2023;10:e002431. doi: 10.1136/openhrt-2023-002431

Publication history

  • Received July 24, 2023
  • Accepted October 11, 2023
  • First published November 7, 2023.
Online issue publication 
February 13, 2024

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.